Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons:: Decreased glucuronidative activity of the UGT1A10139LYS isoform

被引:71
作者
Dellinger, Ryan W.
Fang, Jia-Long
Chen, Gang
Weinberg, Rebecca
Lazarus, Philip
机构
[1] Penn State Univ, Coll Med, Penn State Canc Inst, Canc Prevent & Control Program,Div Populat Sci &, Hershey, PA 17033 USA
[2] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA
[3] Penn State Univ, Coll Med, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA
关键词
D O I
10.1124/dmd.105.009100
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferase 1A10 (UGT1A10) is an extrahepatic enzyme expressed in aerodigestive tract tissues that exhibits significant glucuronidation activity against the important procarcinogenic benzo(a) pyrene (BaP) metabolite, BaP-trans-7,8-dihydrodiol (BPD), and the UGT1A10 codon 139 (Glu > Lys) polymorphism was previously implicated in risk for orolaryngeal cancer by Elahi et al. in their 2003 study. To better assess the potential role of UGT1A10 in risk for tobacco-related cancers, the glucuronidation activity of UGT1A10 was compared with that of other known UGT enzymes against selected polycyclic aromatic hydrocarbons, and the effects of the codon 139 polymorphism on UGT1A10 function were examined in vitro. UGT1A10 exhibited considerably more glucuronidation activity as determined by V-max/K-m against 3-hydroxy (OH)-BaP, 7-OH-BaP, 9-OH-BaP, and 1-OH-pyrene than any other UGT1A family member. Although a kinetic comparison using V-max could not be performed against family 2B UGTs, UGT1A10 exhibited a 1.7- to 254-fold lower K-m than active family 2B UGTs against 3-OH-BaP, 7-OH-BaP, and 1-OH-pyrene. A significantly (p < 0.01) higher V-max/K-m was observed for homogenates from wild-type UGT1A10(139Glu)-overexpressing cells against all four BaP metabolites tested (3-OH-BaP, 7-OH-BaP, 9-OH-BaP, and BPD). A similarly significant (p < 0.05) increase in V-max/K-m was observed for homogenates from wild-type UGT1A10(139Glu)-overexpressing cells against 1-OH-pyrene. Significant differences in K-m were observed for homogenates from wild-type UGT1A10(139Glu)-overexpressing cells against 1-OH-pyrene (p < 0.05) and 3-OH-BaP (p < 0.01). Reverse transcription-polymerase chain reaction of total lung RNA showed low levels of UGT1A10 expression in human lung tissue. Together, these studies implicate UGT1A10 as an important detoxifier of polycyclic aromatic hydrocarbons in humans and that the UGT1A10 codon 139 polymorphism may be an important determinant in risk for tobacco-related cancers.
引用
收藏
页码:943 / 949
页数:7
相关论文
共 30 条
[1]   Polymorphism of UDP-glucuronosyltransferase 1A7 gene:: A possible new risk factor for lung cancer [J].
Araki, J ;
Kobayashi, Y ;
Iwasa, M ;
Urawa, N ;
Gabazza, EC ;
Taguchi, O ;
Kaito, M ;
Adachi, Y .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) :2360-2365
[2]   Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation [J].
Basu, NK ;
Kubota, S ;
Meselhy, MR ;
Ciotti, M ;
Chowdhury, B ;
Hartori, M ;
Owens, IS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (27) :28320-28329
[3]   Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme [J].
Beaulieu, M ;
Levesque, E ;
Tchernof, A ;
Beatty, BG ;
Belanger, A ;
Hum, DW .
DNA AND CELL BIOLOGY, 1997, 16 (10) :1143-1154
[4]   Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11 [J].
Beaulieu, M ;
Lévesque, E ;
Hum, DW ;
Bélanger, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (01) :44-50
[5]   Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues [J].
Bélanger, A ;
Hum, DW ;
Beaulieu, M ;
Lévesque, E ;
Guillemette, C ;
Tchernof, A ;
Bélanger, G ;
Turgeon, D ;
Dubois, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 65 (1-6) :301-310
[6]   Molecular genetic basis of Gilbert's syndrome [J].
Burchell, B ;
Hume, R .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (10) :960-966
[7]   Isolation and characterization of the human UGT2B7 gene [J].
Carrier, JS ;
Turgeon, D ;
Journault, K ;
Hum, DW ;
Bélanger, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (02) :616-621
[8]   Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications [J].
Ciotti, M ;
Marrone, A ;
Potter, C ;
Owens, IS .
PHARMACOGENETICS, 1997, 7 (06) :485-495
[9]  
ELAHI A, 2003, CANCER, V15, P872
[10]  
Fang JL, 2002, CANCER RES, V62, P1978